Bayer Announces Positive Phase I Data - Analyst Blog The HealthCare segment of Bayer ( BAYRY ) recently announced positive results from a phase I study on prothrombin complex concentrates (PCCs). The study evaluated three and four factor PCCs in
July 8, 2013 - Nasdaq